On cancer incidence in multiple sclerosis and effects of immunomodulatory treatments.
Paul D
PD
Feigin
D005260:Female; D000068717:Glatiramer Acetate; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D015994:Incidence; D009103:Multiple Sclerosis / Q000188:drug therapy*; D009369:Neoplasms / Q000139:chemically induced* / Q000453:epidemiology; D010455:Peptides / Q000009:adverse effects*
D007166:Immunosuppressive Agents; D010455:Peptides; D000068717:Glatiramer Acetate